Literature DB >> 8132740

A benign cultured colon adenoma bears three genetically altered colon cancer oncogenes, but progresses to tumorigenicity and transforming growth factor-beta independence without inactivating the p53 tumor suppressor gene.

S D Markowitz1, L Myeroff, M J Cooper, J Traicoff, M Kochera, J Lutterbaugh, M Swiriduk, J K Willson.   

Abstract

We describe the spontaneous progression of a colon adenoma cell line to tumorigenicity and growth factor independence. This system allows direct comparison of biologic stages of malignant progression with alterations of colon cancer suppressor genes and oncogenes. VACO-235, a human colon adenoma cell line, is at early passages nontumorigenic in the nude mouse, unable to grow in soft agar, growth stimulated by serum and EGF, and growth inhibited by TGF-beta. VACO-235 daughter passages 93 and higher have in culture spontaneously progressed to being weakly tumorigenic, but retain all other growth characteristics of VACO-235 early passages. A mouse xenograft from late passage VACO-235 was reestablished in culture as the granddaughter cell line, VACO-411. VACO-411 is highly tumorigenic, clones in soft agar, and is unresponsive to serum, EGF, and TGF-beta. Early passage VACO-235 bears a mutant K-ras allele, bears only mutant APC alleles, expresses no DCC transcripts, and expresses only wild type p53 transcripts. VACO-411 retains the identical genotype, still expressing only wild type p53. Colonic cells after ras mutation, APC mutation, and DCC inactivation remain nontumorigenic and growth factor dependent. Malignant progression involves at least two additional steps, and in VACO-411 can proceed by a novel pathway not requiring p53 inactivation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8132740      PMCID: PMC294021          DOI: 10.1172/JCI117048

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  35 in total

1.  Loss of growth control by TGF-beta occurs at a late stage of mouse skin carcinogenesis and is independent of ras gene activation.

Authors:  S Haddow; D J Fowlis; K Parkinson; R J Akhurst; A Balmain
Journal:  Oncogene       Date:  1991-08       Impact factor: 9.867

2.  Amplification of a gene encoding a p53-associated protein in human sarcomas.

Authors:  J D Oliner; K W Kinzler; P S Meltzer; D L George; B Vogelstein
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

3.  Antisense RNA to the putative tumor-suppressor gene DCC transforms Rat-1 fibroblasts.

Authors:  R Narayanan; K G Lawlor; R Q Schaapveld; K R Cho; B Vogelstein; P Bui-Vinh Tran; M P Osborne; N T Telang
Journal:  Oncogene       Date:  1992-03       Impact factor: 9.867

4.  Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor beta (TGF-beta): conversion of an adenoma cell line to a tumorigenic phenotype is accompanied by a reduced response to the inhibitory effects of TGF-beta.

Authors:  A M Manning; A C Williams; S M Game; C Paraskeva
Journal:  Oncogene       Date:  1991-08       Impact factor: 9.867

5.  Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients.

Authors:  I Nishisho; Y Nakamura; Y Miyoshi; Y Miki; H Ando; A Horii; K Koyama; J Utsunomiya; S Baba; P Hedge
Journal:  Science       Date:  1991-08-09       Impact factor: 47.728

6.  Progression of colorectal cancer is associated with multiple tumor suppressor gene defects but inhibition of tumorigenicity is accomplished by correction of any single defect via chromosome transfer.

Authors:  M C Goyette; K Cho; C L Fasching; D B Levy; K W Kinzler; C Paraskeva; B Vogelstein; E J Stanbridge
Journal:  Mol Cell Biol       Date:  1992-03       Impact factor: 4.272

7.  A single human colonic adenoma cell line can be converted in vitro to both a colorectal adenocarcinoma and a mucinous carcinoma.

Authors:  C Paraskeva; A Hague; N Rooney; A C Williams; S J Harper; K A Hanlon; R J Atkinson; A P Corfield
Journal:  Int J Cancer       Date:  1992-06-19       Impact factor: 7.396

8.  Accumulation of p53 tumor suppressor gene protein: an independent marker of prognosis in breast cancers.

Authors:  A D Thor; I I Moore DH; S M Edgerton; E S Kawasaki; E Reihsaus; H T Lynch; J N Marcus; L Schwartz; L C Chen; B H Mayall
Journal:  J Natl Cancer Inst       Date:  1992-06-03       Impact factor: 13.506

9.  Cloning and sequencing of a deoxyribonucleic acid copy of glyceraldehyde-3-phosphate dehydrogenase messenger ribonucleic acid isolated from chicken muscle.

Authors:  A Dugaiczyk; J A Haron; E M Stone; O E Dennison; K N Rothblum; R J Schwartz
Journal:  Biochemistry       Date:  1983-03-29       Impact factor: 3.162

10.  TGF-beta 1 is an autocrine-negative growth regulator of human colon carcinoma FET cells in vivo as revealed by transfection of an antisense expression vector.

Authors:  S P Wu; D Theodorescu; R S Kerbel; J K Willson; K M Mulder; L E Humphrey; M G Brattain
Journal:  J Cell Biol       Date:  1992-01       Impact factor: 10.539

View more
  8 in total

1.  The aberrant methylation of TSP1 suppresses TGF-beta1 activation in colorectal cancer.

Authors:  Andres Rojas; Shereen Meherem; Young-Ho Kim; Mary Kay Washington; Joseph E Willis; Sanford D Markowitz; William M Grady
Journal:  Int J Cancer       Date:  2008-07-01       Impact factor: 7.396

Review 2.  Defects of TGF-beta receptor signaling in mammary cell tumorigenesis.

Authors:  M G Brattain; Y Ko; S S Banerji; G Wu; J K Willson
Journal:  J Mammary Gland Biol Neoplasia       Date:  1996-10       Impact factor: 2.673

3.  The BAD protein integrates survival signaling by EGFR/MAPK and PI3K/Akt kinase pathways in PTEN-deficient tumor cells.

Authors:  Qing-Bai She; David B Solit; Qing Ye; Kathryn E O'Reilly; Jose Lobo; Neal Rosen
Journal:  Cancer Cell       Date:  2005-10       Impact factor: 31.743

4.  RET is a potential tumor suppressor gene in colorectal cancer.

Authors:  Y Luo; K D Tsuchiya; D Il Park; R Fausel; S Kanngurn; P Welcsh; S Dzieciatkowski; J Wang; W M Grady
Journal:  Oncogene       Date:  2012-07-02       Impact factor: 9.867

5.  Prognostic value of loss of heterozygosity and sub-cellular localization of SMAD4 varies with tumor stage in colorectal cancer.

Authors:  Xu Jia; Chandrakumar Shanmugam; Ravi K Paluri; Nirag C Jhala; Michael P Behring; Venkat R Katkoori; Shajan P Sugandha; Sejong Bae; Temesgen Samuel; Upender Manne
Journal:  Oncotarget       Date:  2017-03-21

6.  Stromal uptake and transmission of acid is a pathway for venting cancer cell-generated acid.

Authors:  Alzbeta Hulikova; Nicholas Black; Lin-Ting Hsia; Jennifer Wilding; Walter F Bodmer; Pawel Swietach
Journal:  Proc Natl Acad Sci U S A       Date:  2016-08-19       Impact factor: 11.205

Review 7.  Is mucinous carcinoma of the colorectum a distinct genetic entity?

Authors:  C Hanski
Journal:  Br J Cancer       Date:  1995-12       Impact factor: 7.640

8.  Black Raspberries Enhance Natural Killer Cell Infiltration into the Colon and Suppress the Progression of Colorectal Cancer.

Authors:  Pan Pan; Siwen Kang; Youwei Wang; Ka Liu; Kiyoko Oshima; Yi-Wen Huang; Jianying Zhang; Martha Yearsley; Jianhua Yu; Li-Shu Wang
Journal:  Front Immunol       Date:  2017-08-16       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.